STUART, Fla., Jan. 9 /PRNewswire-FirstCall/ -- Liberator Medical Supply, Inc. (OTC Bulletin Board: LBMH), the wholly-owned subsidiary of Liberator Medical Holdings, Inc., announced today that it has exceeded management's expectations for December's gross sales and has set a new company record for the highest monthly and quarterly sales ever.
"We believe that Liberator is approaching the break-even point and that we anticipate reaching that point by March at the current rate of revenue growth," said Robert Davis, CFO. "On an annualized basis, since last July we have grown over 100% in gross sales and this first quarter of Fiscal 2008 represents an increase of 70% over the last quarter of fiscal 2007," said Mr. Davis. In the past quarter we have realized revenue growth in direct-to- consumer segment products in diabetes, masectomy and urology.
Mark Libratore, CEO, commented: "Our marketing efforts continue to provide consistent and sustainable growth at more than acceptable customer acquisition costs. It is important to keep in mind that much of the revenue generated during this latest growth cycle shall reoccur on a monthly or quarterly basis for years to come due to the re-order patterns of our customers." Mr. Libratore added, "The company has obtained outside capital in the past and will require additional capital in order to sustain our rapid growth until we are well past break-even, at which time we will be able to self-fund much of our growth. To that end we have been in discussions with both large and smaller funding sources on a continual basis."
About Liberator Medical Supply, Inc.
Liberator Medical Supply, Inc. is a national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider Accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. The Company is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Approximately 75% of its revenue comes from supplying products to meet the rapidly growing requirements of Diabetes, Urological, Ostomy and Mastectomy patients. The Company communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
Certain statements in this press release that are not historical, but are forward-looking, are subject to known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this press release. Such risks and uncertainties may include, but are not limited to, the Company's need to raise equity capital and its ability to obtain equity financing on acceptable terms, if at all, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services, commercial acceptance and viability of new services, pricing and competition, reliance upon subcontractors, the timing of new technology and product introductions, and the risk of early obsolescence. Further, Liberator Holdings is a development stage company that operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond the Company's control, such as announcements and product development by competing product and competing service providers.
|SOURCE Liberator Medical Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved